| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.2M | +13.9% |
| Cost of Revenue | $14.9M | +69.5% |
| Gross Profit | $15.3M | -13.6% |
| R&D Expense | $26.5M | +51.0% |
| SG&A Expense | $18.9M | -3.5% |
| Operating Income | -$61.8M | -55.0% |
| Pre-tax Income | -$59.7M | -71.8% |
| Income Tax | $97K | +506.3% |
| Net Income | -$59.8M | -72.0% |
| EPS (Basic) | -$3.12 | -47.9% |
| EPS (Diluted) | -$3.12 | -47.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.6M | +143.7% |
| Short-term Investments | $18.9M | -3.0% |
| Accounts Receivable | $5.4M | -14.8% |
| Current Assets | $64.1M | +45.7% |
| Total Assets | $113.8M | +75.4% |
| Current Liabilities | $10.1M | +31.3% |
| Total Liabilities | $16.2M | +70.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.4M | -70.0% |
| Capital Expenditures | $934K | -3.3% |
| Investing Cash Flow | $3.8M | -85.5% |
| Financing Cash Flow | $60.5M | +1148.1% |
| Free Cash Flow | -$45.3M | -67.4% |
| Stockholders' Equity |
| $97.6M |
| +76.2% |